The CPSM has, for several years, been working on a number of quality improvement initiatives related to the prescribing of drugs with potential for abuse. These efforts were expanded and formalized under the Prescribing Practices Program in the summer of 2018. Some components of this program are well established, while others are in the development or early implementation phase. Some of the most notable outcomes of this program are reported below.

The CPSM Prescribing Practices Program includes the following components: